Molecular interactions in the Vogelstein model of colorectal carcinoma

Journal of Pathology

Volumn 190, Issue 4, 2000, Pages 412-416

  Arends, Jan Willem ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

APC; Colorectal carcinoma; k Ras; p53; TGF ; Vogelstein model; Wnt

Indexed keywords

PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

CARCINOGENESIS; CELL CYCLE; COLON POLYPOSIS; COLORECTAL CARCINOMA; HUMAN; MOLECULAR INTERACTION; MOLECULAR MODEL; MUTATION; ONCOGENE K RAS; PRIORITY JOURNAL; REVIEW;

CELL COMMUNICATION; COLORECTAL NEOPLASMS; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASM PROTEINS; ONCOGENES;

EID: 0034103928     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200003)190:4<412::AID-PATH533>3.0.CO;2-P     Document Type: Review

References (38)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell 1990; 61: 759-767.
2. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
3. Ilyas M, Tomlinson IPM. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol 1997; 182: 128-137.
4. Behrens J, Jerchow BA, Würtele M, et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 1998; 280: 596-599.
5. He TC, Sparks AB, Rago C, et al. Identification of c-myc as a target of the APC pathway. Science 1998; 281: 1509-1512.
6. Facchini LM, Penn LZ. The molecular role of myc in growth and transformation: recent discoveries lead to new insights. FASEB J 1998; 12: 633-651.
7. Wu KJ, Polack A, Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-Myc. Science 1999; 283: 676-679.
8. Lange de T, Depinho RA. Unlimited mileage from lelomerase? Science 1999; 283: 947-949.
9. Bos JL. Ras oncogenes in human colon cancer: a review. Cancer Res 1989; 49: 4682-4686.
10. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-1321.
11. arf links the tumour suppressor p53 to Ras. Nature 1998; 395: 125-126.
12. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-426.
13. Keino-Masu K, Masu M, Hinck L, et al. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 1996; 87: 175-185.
14. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.
15. Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature 1996; 13: 343-346.
16. Moskaluk CA, Kern SE. Cancer gets mad: DPC4 and other TGFβ pathway genes in human cancer. Biochim Biophys Acta 1996; 1288: M31-M33.
17. Eppert K, Scherer SW, Ozcelik H, et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86: 543-552.
18. de Caestecker MP, Parks WT, Frank CJ, et al. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 1998; 12: 1587-1592.
19. Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995; 55: 5548-5550.
20. Hall PA, Meek D, Lane DP. p53 - integrating the complexity. J Pathol 1996; 180: 1-5.
21. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
22. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187: 112-126.
23. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997; 3: 231-234.
24. kip1 degradation and anchorage independence by Ras through the MAP kinase signalling pathway. Oncogene 1997; 15: 629-637.
25. Waltzer L, Bienz M. Drosophila CBP represses the transciption factor TCF to antagonize Wingless signalling. Nature 1998; 395: 521-525.
26. Sevignani C, Wlodarski P, Kirillova J, et al. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene. J Clin Invest 1998; 101: 1572-1580.
27. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 1993; 85: 2004-2007.
28. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339: 1277-1284.
29. Arends JW, Bosman FT. The conceptual and practical impact of Ki-ras mutation in colorectal neoplasia. J Pathol 1996; 180: 355-356.
30. Jen J, Powell SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523-5526.
31. Smith AJ, Stern HS, Penner M, et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res. 1994; 54: 5527-5530.
32. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Ape genes. Cell 1998; 92: 645-656.
33. Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med 1999; 5: 11-12.
34. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
35. Clarke AR, Cummings MC, Harrison DJ. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 1995; 11: 1913-1920.
36. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-3460.
37. Herbergs J, Hopman AHN, de Bruïne AP, Ramaekers FCS, Arends JW. In situ hybridization and flow cytometric analysis of colorectal tumours suggests two routes of tumourigenesis characterized by gain of chromosome 7 or loss of chromosomes 17 and 18. J Pathol 1996; 179: 243-247.
38. Bardi G, Pandis N, Fenger C, Kronborg O, Bomme L, Heim S. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res 1993; 10: 190-196.